Welcome to BOS Basel 2019. The event which brings together stakeholders in pharmaceutical R&D outsourcing to share experience, develop knowledge and skills and build new and existing business partnerships. The scope of the event for 2019 will cover Discovery Outsourcing and Development Stage CMC Outsourcing for both Small Molecules and Biologics.
We look forward to building on a highly successful event in 2018 where delegate numbers increased by over 30% and average ratings reached 8 out of 10 (up from 7.68 in 2017). We look forward to developing the event further in 2019 to meet all your Discovery and CMC outsourcing needs.
The BOS Event Formula - Presentations/Partnering/Exhibition/Informal Networking
Our CMC Outsourcing Module is divided into small molecule and biologics tracks and includes the following components: Outsourcing Business Process: Early Development CMC Outsourcing: Late Stage CMC Outsourcing: CMC Outsourcing Case Studies: BOS Outsourcing Showcase Poster Presentations. Within this scope, our programme will be shaped to resonate with SME biotech, large pharma, and CMO alike.
Our Discovery Outsourcing Module will have a dedicated Discovery Outsourcing Track which will encompass target site identification, target site validation, lead identification, lead validation, discovery chemistry and discovery biology. Within this scope the 2 day programme will include the following components: Outsourcing Business Process: Early Stage Discovery Outsourcing: Late Stage Discovery Outsourcing: Discovery Outsourcing Case Studies: BOS Outsourcing Showcase Posters: Open Innovation in Discovery
Partnering: Every attendee has access to our partnering software no later than 2 weeks before the event. Biotech and Pharma attendees can use the partnering software to outline services and capabilities they may require. Based on these requirements, attending CROs and CMOs can then request a 1-to-1 meeting to discuss these requirements further. This partnering dynamic presents a highly effective platform which brings buyers and suppliers together.
Exhibition: The BOS 2019 exhibition will feature leading international CROs and CMOs. We will also showcase innovation in the field of CMC and Discovery capabilities and technologies through submitted posters which will be integrated into the networking space at the Congress Centre Basel.
Informal Networking: Meet with peers in the industry over coffee or at the drinks receptions which follow the close of day 1 and day 2 proceedings. The event size and the partnering ethos of the event create a friendly, open atmosphere which encourages informal networking and the creation of new business relationships.
Here’s what attendees at BOS 2018 said about the event:
"BOS Basel 2018 was a success as it provided the opportunity to introduce ProQR Therapeutics NV, gave the forum to network with existing CDMO’s and get in-touch with new CDMO’s and (re-)connect with CMC colleagues in the pharma industry.” Maarten Van Geffen, Senior Director, Clinical Supplies & Logistics, ProQR Therapeutics
"The expansion to discovery has broadened the conference and have brought in a complementary focus.” Dr Alexander Bausch, CEO, Strekin AG
"BOS 2018 in Basel, especially attending the biologics workstream, was a very valuable event for me, with excellent presentations on outsourcing biologics development and manufacture and great opportunities for networking and partnering.” Ulrich Ruemenapp, Head of Launch Preparation and Coordination, Bayer
“This year’s BOS conference in Basel was a real success for Concept Life Sciences. The dual tracks of discovery and CMC were particularly powerful in broadening the delegate attendance and a great complement to our integrated discovery and development services. It’s good to see this event growing year on year, and we look forward to contributing to the poster and presentation sessions that were also a very good component of this year’s event." Simon Bristow VP BD Pharmaceutical Development & Preclinical, Concept Life Sciences